Adherence with controller medication in adults with asthma–impact of hospital admission for acute exacerbation

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Adherence with controller medication in adults with asthma–impact of hospital admission for acute exacerbation. / Staehr Holm, Freja; Håkansson, Kjell Erik Julius; Ulrik, Charlotte Suppli.

In: Journal of Asthma, Vol. 59, No. 9, 2022, p. 1899-1907.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Staehr Holm, F, Håkansson, KEJ & Ulrik, CS 2022, 'Adherence with controller medication in adults with asthma–impact of hospital admission for acute exacerbation', Journal of Asthma, vol. 59, no. 9, pp. 1899-1907. https://doi.org/10.1080/02770903.2021.1971702

APA

Staehr Holm, F., Håkansson, K. E. J., & Ulrik, C. S. (2022). Adherence with controller medication in adults with asthma–impact of hospital admission for acute exacerbation. Journal of Asthma, 59(9), 1899-1907. https://doi.org/10.1080/02770903.2021.1971702

Vancouver

Staehr Holm F, Håkansson KEJ, Ulrik CS. Adherence with controller medication in adults with asthma–impact of hospital admission for acute exacerbation. Journal of Asthma. 2022;59(9):1899-1907. https://doi.org/10.1080/02770903.2021.1971702

Author

Staehr Holm, Freja ; Håkansson, Kjell Erik Julius ; Ulrik, Charlotte Suppli. / Adherence with controller medication in adults with asthma–impact of hospital admission for acute exacerbation. In: Journal of Asthma. 2022 ; Vol. 59, No. 9. pp. 1899-1907.

Bibtex

@article{73c5064598cc4c68b84befd22bbb79c7,
title = "Adherence with controller medication in adults with asthma–impact of hospital admission for acute exacerbation",
abstract = "Objective: Uncontrolled asthma is associated with higher risk of hospital admissions and death. Low adherence to inhaled corticosteroid (ICS), the cornerstone of asthma therapy, is well-documented. Our aim was to investigate if hospital admission with an acute exacerbation of asthma changes ICS adherence. Methods: This retrospective cohort study comprises 241 patients hospitalized with an asthma exacerbation over 12 months (May 2019–April 2020). The primary outcome was proportion of ICS adherent patients, defined as Medication Possession Ratio (MPR) ≥80%, in the six-month period before and after admission. Results: The pre- to post-admission proportion of ICS adherent patients increased from 10% to 13% (p = 0.25) and the mean ICS MPR increased from 34% to 42% (p < 0.001). Different patterns of post-discharge adherence were observed, as adherent patients remained adherent, while patients with poor pre-admission adherence increased their adherence during two months after discharge followed by a decline in MPR. Co-variates such as sex, age, body mass index (BMI), GINA 2020-treatment step did not predict improvement in adherence after discharge. Conclusions: Admission with an asthma exacerbation did not increase the proportion of patients adherent with controller medication, primarily ICS. Although an improvement in adherence was initially seen primarily in previously poorly adherent patients, this increase was transient as it decreased over time post-discharge.",
keywords = "compliance, hospitalization, Inhaled corticosteroids, medication possession ratio, severe exacerbation of asthma",
author = "{Staehr Holm}, Freja and H{\aa}kansson, {Kjell Erik Julius} and Ulrik, {Charlotte Suppli}",
note = "Publisher Copyright: {\textcopyright} 2021 Taylor & Francis Group, LLC.",
year = "2022",
doi = "10.1080/02770903.2021.1971702",
language = "English",
volume = "59",
pages = "1899--1907",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Taylor & Francis",
number = "9",

}

RIS

TY - JOUR

T1 - Adherence with controller medication in adults with asthma–impact of hospital admission for acute exacerbation

AU - Staehr Holm, Freja

AU - Håkansson, Kjell Erik Julius

AU - Ulrik, Charlotte Suppli

N1 - Publisher Copyright: © 2021 Taylor & Francis Group, LLC.

PY - 2022

Y1 - 2022

N2 - Objective: Uncontrolled asthma is associated with higher risk of hospital admissions and death. Low adherence to inhaled corticosteroid (ICS), the cornerstone of asthma therapy, is well-documented. Our aim was to investigate if hospital admission with an acute exacerbation of asthma changes ICS adherence. Methods: This retrospective cohort study comprises 241 patients hospitalized with an asthma exacerbation over 12 months (May 2019–April 2020). The primary outcome was proportion of ICS adherent patients, defined as Medication Possession Ratio (MPR) ≥80%, in the six-month period before and after admission. Results: The pre- to post-admission proportion of ICS adherent patients increased from 10% to 13% (p = 0.25) and the mean ICS MPR increased from 34% to 42% (p < 0.001). Different patterns of post-discharge adherence were observed, as adherent patients remained adherent, while patients with poor pre-admission adherence increased their adherence during two months after discharge followed by a decline in MPR. Co-variates such as sex, age, body mass index (BMI), GINA 2020-treatment step did not predict improvement in adherence after discharge. Conclusions: Admission with an asthma exacerbation did not increase the proportion of patients adherent with controller medication, primarily ICS. Although an improvement in adherence was initially seen primarily in previously poorly adherent patients, this increase was transient as it decreased over time post-discharge.

AB - Objective: Uncontrolled asthma is associated with higher risk of hospital admissions and death. Low adherence to inhaled corticosteroid (ICS), the cornerstone of asthma therapy, is well-documented. Our aim was to investigate if hospital admission with an acute exacerbation of asthma changes ICS adherence. Methods: This retrospective cohort study comprises 241 patients hospitalized with an asthma exacerbation over 12 months (May 2019–April 2020). The primary outcome was proportion of ICS adherent patients, defined as Medication Possession Ratio (MPR) ≥80%, in the six-month period before and after admission. Results: The pre- to post-admission proportion of ICS adherent patients increased from 10% to 13% (p = 0.25) and the mean ICS MPR increased from 34% to 42% (p < 0.001). Different patterns of post-discharge adherence were observed, as adherent patients remained adherent, while patients with poor pre-admission adherence increased their adherence during two months after discharge followed by a decline in MPR. Co-variates such as sex, age, body mass index (BMI), GINA 2020-treatment step did not predict improvement in adherence after discharge. Conclusions: Admission with an asthma exacerbation did not increase the proportion of patients adherent with controller medication, primarily ICS. Although an improvement in adherence was initially seen primarily in previously poorly adherent patients, this increase was transient as it decreased over time post-discharge.

KW - compliance

KW - hospitalization

KW - Inhaled corticosteroids

KW - medication possession ratio

KW - severe exacerbation of asthma

U2 - 10.1080/02770903.2021.1971702

DO - 10.1080/02770903.2021.1971702

M3 - Journal article

C2 - 34425724

AN - SCOPUS:85114405749

VL - 59

SP - 1899

EP - 1907

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 9

ER -

ID: 279821641